Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage N...
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules
About this item
Full title
Author / Creator
Lai, Yanzhen , Wang, Yu , Wu, Yaxian , Wu, Meng , Xing, Shan , Xie, Ying , Chen, Shulin , Li, Xiaohui , Zhang, Ao , He, Yi , Li, Huilan , Dai, Shuqin , Wang, Junye , Lin, Shudai , Bai, Yunmeng , Du, Hongli and Liu, Wanli
Publisher
Los Angeles, CA: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
Los Angeles, CA: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background
Effective means for early diagnosis are imperative to reduce death rate of non-small cell lung cancer (NSCLC) patients. We aimed to find out high-performance serologic markers to distinguish early-stage NSCLC patients from benign pulmonary nodule patients and healthy controls (HC). Cystatin-SN (CST1) is an active cysteine protease inh...
Alternative Titles
Full title
Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4ce634125b614ef89e8e791e4b11e46a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4ce634125b614ef89e8e791e4b11e46a
Other Identifiers
ISSN
1073-2748
E-ISSN
1526-2359,1073-2748
DOI
10.1177/10732748221104661
